Multiple myeloma is the second most common blood cancer in the United States. Thirty to 50 percent of multiple myeloma patients have extra copies of the gene that encodes the enzyme ADAR1. Using a database of multiple myeloma patient samples and...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2zTH0tI
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Kimchi was prepared with different types of salts: purified salt (PS), solar salt aged for 1 year (SS1), aged for 3 years (SS3), a...
-
Abstract Although Nobori ® , with a bioresorbable polymer and biolimus A9 abluminal coating, has unique characteristics, few data exist re...
-
http://ift.tt/2rdV14q
-
Abstract In this study we investigated whether exerting an impulse on a Chronic Total Occlusion (CTO) improves the success rate of CTO cro...
-
Publication date: June 2017 Source: Anesthesiology Clinics, Volume 35, Issue 2 Author(s): Anair Beverly, Alan D. Kaye, Olle Ljungqvist, R...
-
At the King’s Fund’s annual conference on leadership and management last week, NHS England’s chief executive, Simon Stevens, found an innova...
-
Zusammenfassung Nichtmelanozytärer Hautkrebs und seine Frühformen sind aufgrund von steigender Inzidenz und Prävalenz häufige Diagnosen im...
-
2016-10-05T05-46-18Z Source: International Journal of Research in Medical Sciences Noha Seada, Mostafa G. M. Mostafa. Background: Heart...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου